Table 2.

Organizing committee - 3rd International HIV/Viral Hepatitis Co-Infection Meeting

Name	Organization	City, Country	Role
Marina Klein	McGill University CIHR Canadian HIV Trials Network (CTN)	Montréal, Canada	Co-chair
Wendy Spearman	University of Cape Town	Cape Town, South Africa	Co-chair
Monique Andersson	Stellenbosch University Faculty of Health Sciences	Stellenbosch, South Africa	Convener of HBV prevention and management theme
Isabelle Andrieux-Meyer	MSF	Geneva, Switzerland	Co-convener of HCV and HBV access theme
Anchalee Avihingsanon	HIV-NAT	Bangkok, Thailand	Co-convener of epidemiology and disease burden theme
Sanjay Bhagani	Royal Free Hospital	London, UK	Co-convener of complex issues in HCV and HBV theme
Christoph Boesecke	University of Bonn	Bonn, Germany	EACS Liaison
Laurent Castera	Hôpital Beaujon	Paris, France	EASL Liaison
Curtis Cooper	CIHR Canadian HIV Trials Network (CTN)	Ottawa, Canada	Co-convener of HCV therapeutic development theme
Greg Dore	Kirby Institute, University of New South Wales	Sydney, Australia	Convener of treatment in special populations theme
Jordan Feld	University of Toronto	Toronto, Canada	Convener of HBV therapeutic development theme
Karine Lacombe	Hôpital Saint-Antoine	Paris, France	Convener of epidemiology and disease burden theme
Gail Matthews	Kirby Institute, University of New South Wales	Sydney, Australia	Convener of complex issues in HCV and HBV theme
Sébastien Morin	International AIDS Society	Geneva, Switzerland	Point contact for coordination with the IAS and AIDS 2016
Marion Peters	University of California	San Francisco, USA	Co-convener of HBV therapeutic development theme
Jürgen Rockstroh	University of Bonn	Bonn, Germany	Convener of treatment in special populations theme
Mark Sulkowski	Viral Hepatitis Center, Johns Hopkins Division of Infectious Diseases	Baltimore, USA	Convener of HCV therapeutic development theme
Tracy Swan	MSF Access Campaign	New York, USA	Convener of HCV and HBV access theme